Genetic variation in the glucose-dependent insulinotropic peptide receptor (GIPR), and obesity-risk genes like FTO rs9939609 and MC4R rs17782313 may influence how your body responds to appetite-suppressing medications
In contrast, DPP-4 inhibitors prevent enzymatic inactivation of endogenous GLP-1, resulting in prolonged availability of physiological levels of native GLP-1 and GIP and modest receptor activation [1]
10.1111/aji.13349 50 KarlssonO.RodosthenousR
Doses above 2ml per injection may elevate homocysteine levels if B-vitamin cofactors (B6, B12, folate) are insufficient, which can contribute to vascular inflammation over time
Muscle mass directly determines metabolic rate, functional capacity, insulin sensitivity, and long-term health outcomes
One role of GLP-1 is to prompt the body to produce more insulin, which reduces blood (sugar)